Psychomotor and Anxiolytic Effects????????? of Mexazolam in Patients with Generalised Anxiety Disorder-Reference-Cited by-同舟云学术

Psychomotor and Anxiolytic Effects????????? of Mexazolam in Patients with Generalised Anxiety Disorder

Published:2003 Issue:4 Volume:23 Page:235-243
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Ferreira Lu??s,Figueira Maria-Lu??sa,Bessa-Peixoto Alberto,Marieiro Ant??nio,Albuquerque Rodolfo,Paz Cristina,Cerqueira Ana,Dami??o Pedro,Dolgner Ana,Dingemanse Jasper

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference26 articles.

1. Generalized anxiety disorder: comorbidity, comparative biology and treatment

2. Quality of Life in the Anxiety Disorders

3. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

4. Impact of anxiety therapy on patients' quality of life

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem;Pharmacological Reports;2022-09-12

2. Tranquilizer/Anxiolytics: Mexazolam;NeuroPsychopharmacotherapy;2022

3. Tranquilizer/Anxiolytics: Mexazolam;NeuroPsychopharmacotherapy;2020

4. P.190 Mexazolam main metabolite chlorordiazepam affinity to different GABAa a3 receptor subtypes. A comparison with Alprazolam;European Neuropsychopharmacology;2019-12

5. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review;Expert Opinion on Pharmacotherapy;2018-05-24